Literature DB >> 3117677

Differences between the activities of human monoclonal IgG1 and IgG3 subclasses of anti-D(Rh) antibody in their ability to mediate red cell-binding to macrophages.

E Wiener1, A Atwal, K M Thompson, M D Melamed, B Gorick, N C Hughes-Jones.   

Abstract

Four IgG1 and three IgG3 human monoclonal antibodies specific for the blood group D(Rh) antigen were tested for their ability to mediate red cell-binding to macrophages in vitro. The IgG3 monoclonals were found to opsonize at a density of approximately 100 molecules per red cell, whereas the IgG1 antibodies were only active at a level of 10,000 molecules per cell. There was no substantial difference between the two IgG subclasses in their ability to bind to Fc receptors on macrophages and it is suggested that the more potent opsonic activity of IgG3 is the result of the relatively long hinge, leading to greater accessibility to the Fc receptor binding site on the Fc piece.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3117677      PMCID: PMC1454126     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  18 in total

1.  Effect of chemical and enzymatic radioiodination on in vitro human Clq activities.

Authors:  C Heusser; M Boesman; J H Nordin; H Isliker
Journal:  J Immunol       Date:  1973-03       Impact factor: 5.422

2.  The binding of human IgG subclasses to human monocytes.

Authors:  F C Hay; G Torrigiani; I M Roitt
Journal:  Eur J Immunol       Date:  1972-06       Impact factor: 5.532

3.  Primary structure of the "hinge" region of human IgG3. Probable quadruplication of a 15-amino acid residue basic unit.

Authors:  T E Michaelsen; B Frangione; E C Franklin
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

4.  The use of purified 125-I-labelled anti-gamma globulin in the determination of the number of D antigen sites on red cells of different phenotypes.

Authors:  E Rochna; N C Hughes-Jones
Journal:  Vox Sang       Date:  1965 Nov-Dec       Impact factor: 2.144

5.  Manipulative and inherent errors in anti-D quantitation using the AutoAnalyzer.

Authors:  H H Gunson; P K Phillips; F Stratton
Journal:  J Clin Pathol       Date:  1972-03       Impact factor: 3.411

6.  The efficient production of stable, human monoclonal antibody-secreting hybridomas from EBV-transformed lymphocytes using the mouse myeloma X63-Ag8.653 as a fusion partner.

Authors:  K M Thompson; D W Hough; P J Maddison; M D Melamed; N Hughes-Jones
Journal:  J Immunol Methods       Date:  1986-11-20       Impact factor: 2.303

7.  The role of adherence to human mononuclear phagocytes in the destruction of red cells sensitized with non-complement binding IgG antibodies.

Authors:  F W van der Meulen; M van der Hart; A Fleer; A E von dem Borne; C P Engelfriet; J J van Loghem
Journal:  Br J Haematol       Date:  1978-04       Impact factor: 6.998

8.  Characterization of the Fc receptor for IgG on a human macrophage cell line, U937.

Authors:  C L Anderson; G N Abraham
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

9.  The binding of human and guinea-pig IgG subclasses to homologous macrophage and monocyte Fc receptors.

Authors:  M D Alexander; J A Andrews; R G Leslie; N J Wood
Journal:  Immunology       Date:  1978-07       Impact factor: 7.397

10.  The interaction between human monocytes and red cells. Specificity for IgG subclasses and IgG fragments.

Authors:  N Abramson; E W Gelfand; J H Jandl; F S Rosen
Journal:  J Exp Med       Date:  1970-12-01       Impact factor: 14.307

View more
  11 in total

1.  Distinctive role of IgG1 and IgG3 isotypes in Fc gamma R-mediated functions.

Authors:  Z Rozsnyay; G Sármay; M Walker; K Maslanka; Z Valasek; R Jefferis; J Gergely
Journal:  Immunology       Date:  1989-04       Impact factor: 7.397

2.  Human monoclonal antibodies to C, c, E, e and G antigens of the Rh system.

Authors:  K Thompson; G Barden; J Sutherland; I Beldon; M Melamed
Journal:  Immunology       Date:  1990-11       Impact factor: 7.397

3.  Immune deposits in articular cartilage of patients with rheumatoid arthritis have a granular pattern not seen in osteoarthritis.

Authors:  A A Vetto; M Mannik; E Zatarain-Rios; M H Wener
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

4.  Differences between the activities of human monoclonal IgG1 and IgG3 anti-D antibodies of the Rh blood group system in their abilities to mediate effector functions of monocytes.

Authors:  E Wiener; V M Jolliffe; H C Scott; B M Kumpel; K M Thompson; M D Melamed; N C Hughes-Jones
Journal:  Immunology       Date:  1988-10       Impact factor: 7.397

5.  Natural autoantibodies may play a role in ineffective erythropoiesis during megaloblastic haemopoiesis.

Authors:  E Wiener; S N Wickramasinghe
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

6.  The Plasmodium falciparum erythrocyte invasion ligand Pfrh4 as a target of functional and protective human antibodies against malaria.

Authors:  Linda Reiling; Jack S Richards; Freya J I Fowkes; Danny W Wilson; Watcharee Chokejindachai; Alyssa E Barry; Wai-Hong Tham; Janine Stubbs; Christine Langer; John Donelson; Pascal Michon; Livingstone Tavul; Brendan S Crabb; Peter M Siba; Alan F Cowman; Ivo Mueller; James G Beeson
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

7.  The association between naturally acquired IgG subclass specific antibodies to the PfRH5 invasion complex and protection from Plasmodium falciparum malaria.

Authors:  Rupert Weaver; Linda Reiling; Gaoqian Feng; Damien R Drew; Ivo Mueller; Peter M Siba; Takafumi Tsuboi; Jack S Richards; Freya J I Fowkes; James G Beeson
Journal:  Sci Rep       Date:  2016-09-08       Impact factor: 4.379

8.  IgA and IgM protein primarily drive plasma corona-induced adhesion reduction of PLGA nanoparticles in human blood flow.

Authors:  Daniel J Sobczynski; Omolola Eniola-Adefeso
Journal:  Bioeng Transl Med       Date:  2017-05-22

9.  Human IgG3 with extended half-life does not improve Fc-gamma receptor-mediated cancer antibody therapies in mice.

Authors:  Rens Braster; Simran Grewal; Remco Visser; Helga K Einarsdottir; Marjolein van Egmond; Gestur Vidarsson; Marijn Bögels
Journal:  PLoS One       Date:  2017-05-19       Impact factor: 3.240

10.  A stable engineered human IgG3 antibody with decreased aggregation during antibody expression and low pH stress.

Authors:  Seiji Saito; Hiroshi Namisaki; Keiko Hiraishi; Nobuaki Takahashi; Shigeru Iida
Journal:  Protein Sci       Date:  2019-03-22       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.